Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma
- 2 February 2016
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 373 (2), 234-240
- https://doi.org/10.1016/j.canlet.2016.01.028
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009
- Rationales, design and recruitment of the Taizhou Longitudinal StudyBMC Public Health, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver DiseaseClinical Cancer Research, 2008
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinomaJournal of Hepatology, 2005
- Management of hepatocellular carcinomaHepatology, 2005
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewHepatology, 2002
- Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic reviewHepatology, 2002
- Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinomaLiver International, 1986